206 related articles for article (PubMed ID: 2143199)
1. Variable expression of 5 alpha-reductase deficiency: presentation with male phenotype in a child of Greek origin.
Carpenter TO; Imperato-McGinley J; Boulware SD; Weiss RM; Shackleton C; Griffin JE; Wilson JD
J Clin Endocrinol Metab; 1990 Aug; 71(2):318-22. PubMed ID: 2143199
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor levels and 5 alpha-reductase activities in preputial skin and chordee tissue of boys with isolated hypospadias.
Gearhart JP; Linhard HR; Berkovitz GD; Jeffs RD; Brown TR
J Urol; 1988 Nov; 140(5 Pt 2):1243-6. PubMed ID: 3263511
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of human chorionic gonadotropins (HCG) stimulation test in XY-disorders of sex development (XY-DSD) presented in Armed Forces Institute of Pathology.
Sheikh WH; Asif N; Haroon ZH; Ejaz A; Ain QU; Shehzad N
J Pak Med Assoc; 2019 Aug; 69(8):1090-1093. PubMed ID: 31431758
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic analysis and human chorionic gonadotropin stimulation tests in the diagnosis of prepubertal patients with partial 5 alpha-reductase deficiency.
Hiort O; Willenbring H; Albers N; Hecker W; Engert J; Dibbelt L; Sinnecker GH
Eur J Pediatr; 1996 Jun; 155(6):445-51. PubMed ID: 8789759
[TBL] [Abstract][Full Text] [Related]
5. Male pseudohermaphroditism due to steroid 5-alpha-reductase deficiency.
Peterson RE; Imperato-McGinley J; Gautier T; Sturla E
Am J Med; 1977 Feb; 62(2):170-91. PubMed ID: 835597
[TBL] [Abstract][Full Text] [Related]
6. Endocrine and biochemical studies in a 46,XY phenotypically male infant with 17-ketosteroid reductase deficiency.
Ulloa-Aguirre A; Bassol S; Poo J; Mendez JP; Mutchinick O; Robles C; Pérez-Palacios G
J Clin Endocrinol Metab; 1985 Apr; 60(4):639-43. PubMed ID: 2857728
[TBL] [Abstract][Full Text] [Related]
7. Partial androgen resistance associated with secondary 5 alpha-reductase deficiency: identification of a novel qualitative androgen receptor defect and clinical implications.
Jukier L; Kaufman M; Pinsky L; Peterson RE
J Clin Endocrinol Metab; 1984 Oct; 59(4):679-88. PubMed ID: 6480803
[TBL] [Abstract][Full Text] [Related]
8. Prepubertal diagnosis of steroid 5 alpha-reductase deficiency.
Saenger P; Goldman AS; Levine LS; Korth-Schutz S; Muecke EC; Katsumata M; Doberne Y; New MI
J Clin Endocrinol Metab; 1978 Apr; 46(4):627-34. PubMed ID: 755047
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor disorder in three brothers with bifid prepenile scrotum and hypospadias.
Bals-Pratsch M; Schweikert HU; Nieschlag E
Acta Endocrinol (Copenh); 1990 Sep; 123(3):271-6. PubMed ID: 2146851
[TBL] [Abstract][Full Text] [Related]
10. Difficulties in diagnosis and treatment of 5alpha-reductase type 2 deficiency in a newborn with 46,XY DSD.
Walter KN; Kienzle FB; Frankenschmidt A; Hiort O; Wudy SA; van der Werf-Grohmann N; Superti-Furga A; Schwab KO
Horm Res Paediatr; 2010; 74(1):67-71. PubMed ID: 20395661
[TBL] [Abstract][Full Text] [Related]
11. Inherited impairment of nuclear androgen uptake as a cause of familial androgen insensitivity.
Ulloa-Aguirre A; Chavez B; Mendez JP; Saavedra D; Perez-Palacios G
Eur J Obstet Gynecol Reprod Biol; 1988 Aug; 28(4):317-29. PubMed ID: 3139477
[TBL] [Abstract][Full Text] [Related]
12. Reduction of androstenedione by skin in vitro and serum levels of gonadotrophins and androgens in men with hypospadias.
Svensson J; Eneroth P; Gustafsson JA; Ritzén M; Stenberg A
J Endocrinol; 1979 Sep; 82(3):395-401. PubMed ID: 512549
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro studies in a 46, XY phenotypically female infant with 17-ketosteroid reductase deficiency.
Wit JM; van Hooff CO; Thijssen JH; Van den Brande JL
Horm Metab Res; 1988 Jun; 20(6):367-74. PubMed ID: 2971011
[TBL] [Abstract][Full Text] [Related]
14. The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity.
Imperato-McGinley J; Gautier T; Cai LQ; Yee B; Epstein J; Pochi P
J Clin Endocrinol Metab; 1993 Feb; 76(2):524-8. PubMed ID: 8381804
[TBL] [Abstract][Full Text] [Related]
15. High dose androgen therapy in male pseudohermaphroditism due to 5 alpha-reductase deficiency and disorders of the androgen receptor.
Price P; Wass JA; Griffin JE; Leshin M; Savage MO; Large DM; Bu'Lock DE; Anderson DC; Wilson JD; Besser GM
J Clin Invest; 1984 Oct; 74(4):1496-508. PubMed ID: 6480833
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two tests to recognize or exclude 5 alpha-reductase deficiency in prepubertal children.
Greene S; Zachmann M; Manella B; Hesse V; Hoepffner W; Willgerodt H; Prader A
Acta Endocrinol (Copenh); 1987 Jan; 114(1):113-7. PubMed ID: 2880442
[TBL] [Abstract][Full Text] [Related]
17. Possible mechanisms of androgen resistance in 5 alpha-reductase deficiency: implications for the physiological roles of 5 alpha-reductases.
Hodgins MB
J Steroid Biochem; 1983 Jul; 19(1B):555-9. PubMed ID: 6887883
[TBL] [Abstract][Full Text] [Related]
18. Endocrine and immunogenetic evaluation of an XX male infant with perineoscrotal hypospadias.
Kofman-Alfaro S; Valdés E; Terán J; Wachtel SS; Chávez B; Bassol S; Medina M; Pérez-Palacios G
Acta Endocrinol (Copenh); 1985 Mar; 108(3):421-7. PubMed ID: 3920857
[TBL] [Abstract][Full Text] [Related]
19. A cluster of male pseudohermaphrodites with 5 alpha-reductase deficiency in Papua New Guinea.
Imperato-McGinley J; Miller M; Wilson JD; Peterson RE; Shackleton C; Gajdusek DC
Clin Endocrinol (Oxf); 1991 Apr; 34(4):293-8. PubMed ID: 1831738
[TBL] [Abstract][Full Text] [Related]
20. C19 and C21 5 beta/5 alpha metabolite ratios in subjects treated with the 5 alpha-reductase inhibitor finasteride: comparison of male pseudohermaphrodites with inherited 5 alpha-reductase deficiency.
Imperato-McGinley J; Shackleton C; Orlic S; Stoner E
J Clin Endocrinol Metab; 1990 Mar; 70(3):777-82. PubMed ID: 1689740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
